Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity

Schizophrenia (SCZ) and type 2 diabetes (T2D) are clinically associated, and common knowledge attributes this association to side effects of antipsychotic treatment. However, even drug-naive patients with SCZ are at increased risk for T2D. Dopamine dysfunction has a central role in SCZ. It is well-k...

Descripción completa

Detalles Bibliográficos
Autores principales: Gragnoli, C, Reeves, G M, Reazer, J, Postolache, T T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872408/
https://www.ncbi.nlm.nih.gov/pubmed/27093067
http://dx.doi.org/10.1038/tp.2016.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872408/
https://www.ncbi.nlm.nih.gov/pubmed/27093067
http://dx.doi.org/10.1038/tp.2016.50

Ejemplares similares